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Contrasting effects of proinflammatory and T.helper lymphocyte sub-
set-2 cytokines on the 5-lipoxygenase pathway in monocytes. Human
peripheral blood monocytes (HPBMs) express 5-lipoxygenase (5-LO) and
5-LO activating protein (FLAP), and hence have an ability to synthesize
proinfiammatory leukotrienes (LTs). Regulation of 5-LO and FLAP
expression is a major determinant of cellular LT synthesis. We examined
the effects of proinflammatory [interleukin (IL)-1 and interferon (IFN)-y]
and T helper lymphocyte subset 2 (TH-2; IL-4 and IL-13) cytokines on (1)
LTB4 production, and (2) 5-LO and FLAP expression in HPBMs. We
show that IL-i and IFN-y stimulate, whereas IL-4 and IL-13 inhibit
ionophore-activated LTB4 release. The stimulatory effects of IL-I and
IFN-y were apparent at 16 to 36 hours of incubation. IL-i modestly
increased FLAP mRNA and significantly increased 5-LO mRNA steady
state levels at 24 and 36 hours of incubation, respectively. IFN-y did not
change the mRNA or protein expression of either 5-LO or FLAP. The
inhibitory effects of IL-4 and IL-13 were associated with decreased FLAP
mRNA and protein steady state levels. These results demonstrate that
regulation of monocyte LTB4 biosynthesis by different cytokines proceeds
via different pathways that partly involve modulation of the expression of
the key proteins, 5-LO and FLAP. In addition, the contrasting effects of
proinfiammatory and TH-2-derived cytokines on moneyte LTB4 produc-
tion demonstrate mechanisms by which cytokine subpopulations may
modulate monocyte function in inflammation.
In monocytes, the 5-LO pathway is a major route of arachidonic
acid metabolism leading to the formation of LTs [1—4]. The key
enzyme itt this process is 5-LO whose activity requires the
presence of the nuclear membrane bound protein, FLAP [5].
5-LO catalyzes the insertion of molecular oxygen at carbon 5 of
free arachidonic acid converting it to an intermediate, LTA4. The
latter is an unstable epoxide whose metabolism leads to the
generation of all the known LTs [1]. Generation of LTB4 requires
the enzymatic action of LTA4 hydrolase, whereas generation of
the peptidyl-LTs (LTC4 and LTD4) requires the action of a
glutathione-S-transferase.
The LTs have diverse biological effects and are increasingly
incriminated in the pathogenesis of several inflammatory disor-
ders such as asthma, inflammatory bowel disease, psoriasis, rheu-
matoid arthritis, and glomerulonephritis [6, 7]. This is in keeping
with their properties as proinflammatory molecules [1]. LTB4 is a
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potent neutrophil chemotactic agent. It also causes neutrophil
activation and degranulation, and enhances neutrophil-endothe-
hal cell adhesion. LTC4 and LTD4 mediate vasoconstriction,
increase vascular permeability to macromolecules, and enhance
mucous secretion in a variety of vascular beds [6, 7].
Monocyte recruitment and activation is an integral component
of immunologic and inflammatory responses. Cytokines, which
are released at inflammatory sites, modulate monocyte responses
[8—13]. In this regard, proinflammatory cytokines such as IL-i and
IFN-y induce monocyte activation and monokine release [8—101.
On the other hand, lymphokines produced by the helper T-
lymphocyte subset 2 (TH-2) cells, such as IL-4 and IL-13, down-
regulate the inflammatory actions of monocytes [11—13]. They
suppress monocyte production of monokines and increase the
synthesis of IL-i receptor antagonist. The possibility that prom-
flammatoiy [IL-i and 1FN-yJ and TH-2-derived [IL-4 and IL-13]
cytokines differentially regulate the 5-LO pathway in monocytes
has not been fully explored. We and others have already demon-
strated reciprocal regulation of monocyte 15-LO by TH-I and
TH-2 lymphokines [14, 15]. The 15-LO enzyme catalyzes another
major pathway of arachidonic acid metabolism in monocytes that
generates 15-S-HETE and lipoxins, products that antagonize LTs,
and exert anti-inflammatory effects [16—18]. IL-4 and IL-13
induced monocyte 15-LO, whereas IFN-y suppressed 15-LO
induction by either cytokine [14, 15].
In the present study, we examined the effects of proinflamma-
tory (IL-i and IFN-y) and TH-2-derived (IL-4 and IL-13) cyto-
kines on LTB4 production by cultured human peripheral blood
monocytes. We also examined the effects of these cytokines on
monocyte 5-LO and FLAP expression. We demonstrate contrast-
ing effects of proinflammatory and TH2-derived cytokines on the
monocyte 5-LO pathway.
Methods
Materials
Recombinant human 1L-ip, 1L-4, and IL-13 were purchased
form R&D systems (Minneapolis, MN, USA) with a manufactur-
er's ED5O value of 3 to 10 pg/ml (murine helper T-cell line
D10.G4.1), 0.3 to 0.9 ng/ml (murine TH-2 cell line), and 3 to 6
ng/ml (human factor-dependent cell line, TF-1) respectively.
Recombinant IFN-y was purchased from Boehringher Mannheim
(Indianapolis, IN, USA) with a specific activity of 2 x i07 U/mg
(inhibition of cytopathic effect of EMC virus on human amniotic
cells). Human 5-LO and FLAP cDNAs and antibodies were a gift
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from Merck Frosst Laboratories (Canada). Enzyme linked immu-
noassay kits for LTB4 measurement were purchased from Elisa
Technologies (Neogen Corporation, Lexington, KY, USA). DNA
oligolabeling kits were purchased from Pharmacia Biotech Inc.
(Piscataway, NJ, USA). ECL kits for Western blot analysis were
obtained from Amersham (Arlington Heights, IL, USA).
Monocyte isolation and incubation
Fresh buffy coats were obtained from healthy volunteers
(American Red Cross, Atlanta, GA, USA) and subjected to
Ficoll-Hypaque density gradient centrifugation. The mononuclear
cell layer was recovered, washed with Hanks' balanced salt
solution and suspended at 5 x 106 cells/mi in RPMI 1640 medium
supplemented with L-glutamine (200 mg/liter), and antibiotics
(penicillin, streptomycin). Cells were then adhered to 100 x 15
mm polystyrene tissue culture plates for three hours at 37°C in the
presence of 5% CO2. The nonadherent cells were removed by
washing the plates twice with phosphate buffered saline (PBS)
(pH = 7.5), and unless otherwise specified, the adherent cells
were incubated in 10% fetal calf serum-enriched RPM! medium
(37°C, 5% C02) with cytokine or its diluent (control). The latter
constituted of 0.1% bovine serum albumin in PBS. In initial
experiments the adherent cells were scraped and counted. The
number of adherent cells was nearly 20% of the initial number of
plated cells. More than 90% of the adherent cells stained positive
for monocyte nonspecific esterase, and more than 95% were
viable by trypan blue exclusion. Cell viability up to 36 hours of
incubation with and without cytokine was 92 to 94%.
Measurement of L TB4 release
Following incubation with cytokine (or its diluent), monocytes
were washed twice with PBS and reincubated for 30 minutes in
serum-free complete RPMI-1640 medium with 2 fLM of calcium
ionophore A23187. The monocyte supernatant was collected for
LTB4 measurement, and the adherent cells were scraped and
quantitiated for cellular protein using the Bio-Rad protein assay
technique (Bio-Rad, Melville, NY, USA). Levels of LTB4 in
monocyte supernatants were determined using a specific enzyme-
linked immunoassay. Results were expressed as ng LTB4 pro-
duced per mg of monocyte cellular protein per minute. To
ascertain that monocyte cellular protein levels correlated with the
number of viable cells following incubation, we scraped adherent
cells, counted the viable cells, and then measured the protein
content. We found that the various cytokines used did not affect
the number of viable cells recovered, and that the number of
viable cells correlated with cellular protein measurements.
RNiI isolation and analysis
Total cellular RNA was purified from adherent HPBMs by the
Chomczynski and Sacchi method using the RNAzoI reagent
(Biotecx Laboratories, Houston, TX, USA) [191. Expression of
5-LO and FLAP mRNA were analyzed by Northern hybridiza-
tion. Total cellular RNA (20 j.tg) was electrophoresed on a 1%
formaldehyde-agarose gel, transferred to Hybond-N + membrane
(Amersham), and covalently linked by ultraviolet irradiation using
a uv cross-linker (Stratagene, La Jolla, CA, USA). Radiolabeled
probes were prepared using 100 ng of the respective full length
cDNA in a standard protocol for random oligolabeling with [cs32P]
dCTP. Approximately 1 to 2 X 106 cpm of radiolabeled probe
(specific activity = 1 >< iO dpm/.tg DNA) were used per ml of
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Fig. 1. LTB4 production by activated monocytes under control conditions
and following incubation with IL-] and IFN-y. Adherent monocytes were
incubated with or without cytokine for a specified period of time.
Monocytes were then washed with PBS and activated with 2 tM of A23187
for 30 minutes, following which LTB4 was measured in cell supernatants
by ELISA. Symbol (°) indicates LTB4 release by IL-i-treated monocytes
is significantly different from control; (+) indicates LTB4 release by
IFN-y-treated monocytes is significantly different from control. A. Stimu-
lation of A23 187-activated monocyte LTB4 production following 36 hours
of incubation with IL-i and IFN-y. Data are mean sus; N = 10. B.
Dose-response effect of IL-i and IFN-y on activated monocyte LTB4
production at 36 hours of incubation; results of a representative experi-
ment is shown (N = 3). C. Time course of activated monocyte LTB4
production under control conditions () and following incubation with
IL-i (•; 100 pM) and IFN-y (A; 100 pM) (N = 4).
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Fig. 2. LTB4 production by activated monocytes under control conditions
and following incubation with IL-4 and IL-13. Adherent monocytes were
incubated with or without cytokine for a specified period of time.
Monocytes were then washed with PBS and stimulated with 2 M of
A23187 for 30 minutes following which LTB4 was measured in cell
supernatants by ELISA. Asterisk indicates cytokine-stimulated LTB4
production is significantly different from control. A. Inhibition of A23 187-
activated monocyte LTB4 production following 24 hours of incubation
with IL-4 (+) and IL-13 (Y) (N = 5; P < 0.05; data are mean SCM. B.
Inhibition of activated monocyte LTB4 release following 24 hours of
incubation with IL-4 and IL-13 is maintained over cytokine concentrations
ranging from 0.1 to 10 ED50. A representative experiment is presented
with either cytokine; N = 3. C. A representative experiment describing the
time course of monocyte LTB4 production under control conditions and
following incubation with IL-13 at ED50 (500 pM). Symbols are: (S)
control; (V) IL-l3.
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Fig. 3. Effects of IL-I (100 pM) and IFN-y (100 pM) on monocyte 5-LO
mRNA. Following 36 hours of incubation, total monocyte RNA was
purified, and probed for 5-LU mRNA as described in the Methods
section. A. Northern blot demonstrating increased 5-LU mRNA signal
with IL-i but not with IFN-y. GAPDH mRNA signal is shown to
demonstrate equal loading of RNA. B. Densitometric analysis (N = 7) of
monocyte 5-LU mRNA blots revealing statistically significant increases of
24 monocyte 5-LU mRNA levels with IL-I. °P < 0.05 in comparison with
control. Data are mean SCM.
hybridization solution. Hybridizations were performed at 42°C for
16 hours. 5-LU blots were washed with a final stringency of 0.2 X
SSC, 0.1% SDS at 55°C for 30 minutes, and FLAP blots with a
final stringency of 2 >< SSC, 0.1% SDS at 42°C for 30 minutes.
Autoradiography was performed using Hyperfilm-MP (Amer-
sham) with an intensifying screen at —70°C for 8 to 12 hours.
These RNA blots were afterwards stripped using boiling water
with 1% SDS and then reprobed for GAPDH mRNA to ensure
equal loading of RNA. All hybridization signals were subjected to
computer-assisted densitometric analysis. 5-LO and FLAP densi-
tometry signals were normalized by that of GAPDH.
18 S
FLAP 0* —*- I kb
GAPDH I
Western blot analysis
Following the designated incubation time, adherent monocytes
were washed in PBS, suspended in lysis buffer (50 mvs HEPES,
1% Triton X-100, 50 mrvi NaC1, 50 mrvi NaF, 10 m sodium
pyrophosphate, 5 mvt EDTA, 1 mvt Na3VO4, 1 mM phenylmeth-
ylsulfonyl fluoride, 10 mg/liter aprotinin, 10 mg/liter leupeptin),
and sonicated for 10 seconds. Cell debris was separated from
solubilized protein by centrifugatiori at 1200 X g for 10 minutes.
Protein in the supernatant was quantitated using the Bio-Rad
protein assay technique (Bio-Rad). Thirty micrograms of total
protein was then separated by SDS-polyacrylamide gel electro-
phoresis and transferred to nitrocellulose membrane using Trans-
Blot SD electrophoretic transfer cell (Bio-Rad). The membrane
was probed with rabbit anti-human 5-LO and anti-human FLAP
antibodies for one hour following which it was washed with
Fig. 4. Effects of IL-I (100 pM), IFN-y (100 pM), IL-4 (100 pM), and IL-
13 (500 pM) on monocyte FLAP mRNA. Following 24 hours of
incubation, total monocyte RNA was purified, and probed for FLAP
mRNA as described in the Methods section. A. Northern blot
demonstrating decreased FLAP mRNA signal with IL-4 and IL-13. B.
Northern blot demonstrating increased FLAP mRNA signal with IL-I
but not with IFN-y. GAPDH mRNA signal is shown to demonstrate
equal loading of RNA. C. Densitometric analysis (N = 7) of monocyte
FLAP mRNA blots at 24 hours of incubation with cytokines shows
statistically significant decreases of nionocyte FLAP mRNA levels with
IL-4 and IL-13. The increase in FLAP mRNA with IL-I failed to
achieve statistical significance. *P < 0.05 in comparison with control.
Nassar et a!: Cytokine regulation of LTB4 synthesis in monocytes
,
00
,:/
.; B 00•' .;'
//e 1523A
0
C000
>
>.
C
1)
C
a)
(I)
2.0
1.5
1.0
0.5
0.0
18 S
FLAP
—1kb
GAPDH
C
* *
Control IL-i IFN-y IL-4 IL-13
PBS-0.l% Tween. A horseradish peroxidase-labeled anti-rabbit
IgG antibody (Amersham) was applied for one hour then washed
with PBS-0.I% Tween. The hybridization signal was detected
using Enhanced Chemiluminescence (ECL) detection reagents
(ECL, Amersham). The ECL reagents were added as described by
the manufacturer, and autoradiography was performed at room
temperature for one minute.
Statistical methods
Monocyte activated LTB4 release was expressed as mean
standard error of the mean. Differences in monocyte activated
LTB4 release among various conditions were compared by
ANOVA. Student's t-test was used for direct comparisons of
activated LTB4 release by cytokine-treated cells and controls.
Differences were considered significant at P < 0.05.
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Fig. 5. Western blots of monocyte 5-LO and FLAP expression following incubation with cytokine or control. Abbreviations are: M.W., molecular weight
marker; C, control monocytes. A. No change in 5-LO immunoblotting signal with IL-i (100 pM) following 36 hours of incubation. The significance of
the lower band is unknown. B. No change in FLAP immunoblotting signal with either IL-i (100 pM) or IFN-y (100 pM) following 36 hours of incubation.
C. IL-4 (100 pM) and IL-13 (500 pM) significantly decrease monocyte FLAP immunoblotting signal following 24 hours of incubation. D. IL-4 (100 pM)
and IL-13 (500 pM) have no significant effects on 5-LO protein expression following 36 hours of incubation.
Monocyte 5-LO and FLAP mRNA hybridization signal densi-
ties in all conditions were normalized by that of GAPDH, and
expressed as % change in comparison with controls. Monocyte
5-LO and FLAP Western blotting signals were expressed as %
change in comparison with control. The Wilcoxon rank sum test
was used to determine if significant differences were present
between signals obtained from monocytes incubated with cyto-
kines and controls. Differences were considered significant at P <
0.05.
Results
IL-i and IFN-y enhance monocyte LTB4 release
Incubation of monocytes for 36 hours with either IL-i (100 pM)
or IFN-y (100 pM) led to enhanced LTB4 release following
activation with A23 187 (Fig. IA). IL-i-treated monocytes had 4.7
times more LTB4 release (331 59 vs. 72 17 ng/mg/hr; N = 10;
P < 0.05), and IFN-y-treated monocytes had 3.4 times more
LTB4 release (242 54 vs. 72 17 ng!mg!hr; N = 10; P < 0.05)
in comparison with controls. To demonstrate a dose-response
effect, monocytes were incubated with increasing concentrations
of IL-i and IFN-y. Enhancement of LTB4 release by stimulated
monocytes was detected with either cytokine at concentrations
starting at 10 p, and progressively increased with higher concen-
trations (Fig. 1B).
A23 187-activated LTB4 release from control monocytes exhib-
ited a significant and steady decline over 36 hours (Fig. 1C). Most
of this decline occurred over the first 16 hours of incubation
(305 98 ng/mg/hr at 0 hr; 81 24 ng/mglhr at 16 hr; 70 16
nglmg/hr at 36 hr; N 4). The time course pattern of activated
LTB4 release from monocytes treated with either IL-i or IFN-y
was characterized by two phases (Fig. IC): an initial phase over
eight hours in which activated LTB4 release exhibited a steady
decline and was similar to control, and a subsequent phase (16 to
36 hr) manifested by an increase in activated LTB4 release to
values significantly higher than control.
IL-4 and IL-i3 suppress monocyte LTB4 release
Incubation of monocytcs with either IL-4 (100 pM) or IL-13
(500 pM) for 24 hours led to significant decreases in activated
monocyte LTB4 release (Fig. 2). In comparison with controls,
A
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IL-4-treated monocytes had 61% less LTB4 release following
activation with A23187 (34 11 ng/mglhr vs. 87 19 nglmglhr;
N = 5; P < 0.05) (Fig. 2A). Similarly, IL-13-treated monocytes
had 71% less activated LTB4 release in comparison with controls
(25 19 ng/mg/hr vs. 87 19 ng!mglhr; N = 5; P < 0.05). These
effects were apparent with IL-4 at 10-1000 p, and with IL-13 at
50-5000 M corresponding to 0.1 ED50 to 10 ED5() for either
cytokine (Fig. 2B). In a time course study, decreased monocyte
activated LTB4 release with either IL-4 (100 pM) or IL-13 (500
pM) was significant following 24 hours of incubation, but not at
earlier time points (Fig. 2C).
IL-I increases monocyte 5-LO mRNA expression
We next determined if cytokine-mediated changes in activated
LTB4 release are associated with changes in monocyte 5-LU
mRNA steady state levels. Incubation of monocytes with IL-I
(100 pM), but not other cytokines, led to statistically significant
increases in 5-LU mRNA levels following (but not prior to) 36
hours of incubation (Fig. 3). Figure 3A shows increased 5-LU
mRNA hybridization signal with IL-i in comparison with control.
Densitometric analysis of seven such blots revealed an average
2.1 0.4-fold increase in 5-LU mRNA hybridization signal
density with IL-i treatment (Fig. 3B). This increase in 5-LU
mRNA signal density was not seen at earlier time points (data not
shown). IFN-y treated monocytes had an average 1.5 0.4-fold
increase in monocyte 5-LU mRNA levels, which did not reach
statistical significance. IL-4- and IL-13-treated monocytes had
insignificant changes in 5-LU mRNA expression. All values were
standardized by the mRNA expression of the house keeping gene
GAPDH.
IL-4 and IL-13 decrease monocyte FLAP ,nRNA expression
Similarly, we determined the effects of the same cytokines on
monocyte FLAP mRNA expression (Fig. 4). IL-4 and IL-13
significantly decreased monocyte FLAP mRNA expression at (but
not prior to) 24 hours of incubation. Figure 4A shows decreased
FLAP mRNA signal intensity with both IL-4 (100 pM) and IL-13
(500 pM). Analysis of seven such blots (Fig. 4C) revealed a
decrease of 47% 12% (P < 0.05) and 46% 9% (P < 0.05) in
FLAP mRNA expression with IL-4 and IL-13, respectively.
Figure 4B demonstrates increased FLAP mRNA hybridization
signal with IL-I (100 pM) following 36 hours of incubation. In a
time course study (N = 3), this increase was noticed as early as 24
hours (136 25% of control; P> 0.05) and persisted at 36 hours
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(142 32% of control; P > 0.05). At both of these time points
however, statistical significance was not achieved. IFN-y caused a
modest decrease in FLAP mRNA steady state levels at 36 hours
(70 15% of control N = 3; P > 0.05) that did not reach
statistical significance.
IL-4 and IL-13 decrease monocyte FLAP protein expression
We next determined if cytokine-mediated changes in LTB4
release were associated with changes in monocyte 5-LU or FLAP
protein expression (Fig. 5). Western blot analysis showed that
IL-i (100 pM) and IFN-y (100 pM) had no effect of the expression
of either protein. Figure 5A demonstrates no change in 5-LU
immunoblotting signal following 36 hours of incubation with IL-I.
The results with IFN-y are not shown. Figure SB demonstrates no
change in FLAP immunoblotting signal following 36 hours of
incubation with IL-I and IFN-y. In contrast, incubation of mono-
cytes with IL-4 (100 pM) or IL-13 (500 pM) led to a significant
decline in FLAP expression detectable by Western blotting at (but
not prior to) 24 hours of incubation. A representative Western
blot with IL-4 and IL-13 is shown in Figure 5C. Analysis of three
such blots revealed an average 49% decrease in FLAP expression
with IL-4, and 57% decrease with IL-13 (P < 0.05). Finally, IL-4
and IL-13 did not change monocyte 5-LU expression as demon-
strated in Figure SD.
Discussion
Our results demonstrate that IL-i and IFN-y enhance the
release of LTB4 from HPBMs following activation with the
calcium ionophore A23187. This effect is dose and time depen-
dent, and occurs at biologically relevant concentrations. In
marked contrast to the effects of IL-I and IFN-y, the TH-2
cytokines, IL-4 and IL-13, decrease LTB4 release from A23187-
activated monocytes. This effect is time dependent and occurs at
biologically relevant concentrations. These contrasting effects on
activated monocyte LTB4 release cannot be explained by effects
on monocyte viability or adherence which were similar with all
cytokines tested and did not differ from control.
Of interest is that cultured monocytes exhibitied spontaneous
diminution of A23187-activated LTB4 release during the first 16
hours of incubation. This phenomenon was also reported by other
investigators [20]. It remains uncertain whether the in vitro culture
conditions cause a decline in monocyte LTB4 synthesis, or the
technique of monocyte handling and isolation primes monocytes
to higher initial LTB4 synthetic rates. In fact, the isolation
technique subjects monocytes to significant physical and biochem-
ical disturbances, and may cause monocyte activation. It is thus
possible that initial rates of A23 187-activated LTB4 release are
elevated as a reflection of monocyte disturbance during the
isolation technique, and that subsequent rates reflect steady state
levels. Even though these monocytes in culture do not behave and
respond exactly as monocytes in vivo, yet they are structurally and
functionally viable cells. Several investigators have cultured
HPBMs under similar conditions and tested their responses to
cytokine challenge [11, 13—15, 21].
Enhancement of monocyte activated LTB4 release by IL-i and
IFN-y is in agreement with previous reports [20, 211. The decrease
in LTB4 release by A23187-activated monocytes following incu-
bation with IL-4 and IL-13 represent novel findings. The degree of
inhibition of LTB4 release was similar between IL-4 and lL-13
and was observed with cytokinc concentrations 10-fold below the
Control IFN-y
Fig. 6. Expression of LTA4 hydrolase mRNA in human peripheral blood
monocytes incubated under control conditions and with JFN-y (100pM) for
36 hours. Densitometric analysis of 8 such blots showed a statistically
significant increase in LTA4 hydrolase mRNA expression with IFN-y.
*p < 0.05 in comparison with control. Densitometric values were cor-
rected by GAPDH mRNA expression.
manufacturer's ED50 for either cytokine. IL-4 and IL-13 are
known to down-regulate monocyte inflammatory responses and
exert anti-inflammatory effects [11—13]. Inhibition of monocyte
LTB4 release by IL-4 and IL-13 is consistent with their other
anti-inflammatory effects.
Having demonstrated these contrasting effects on monocyte
activated LTB4 release by proinflammatory and TH-2 cytokines,
we then examined whether such effects are associated with
changes in monocyte 5-LU and/or FLAP expression. Significant
findings in this regard were the effects of IL-4 and IL-13 on FLAP
mRNA and protein expression. Incubation of monocytes for 24
hours with either IL-4 or IL-13 led to a significant decrease in
FLAP mRNA and protein expression. This decline in FLAP
expression occurred in association with the decrease in activated
LTB4 release. Despite the lack of an effect on monocyte 5-LU
expression, the demonstrated decline in FLAP expression is likely
to reduce monocyte 5-LU activity and diminish LT synthesis
[22—24]. In this regard, the importance of FLAP for expression of
5-LO activity and LT synthesis comes from experiments demon-
strating a correlation between expression of FLAP and cellular
LT synthesis [23, 24], and also from the fact that FLAP inhibition
by MK886 completely suppresses cellular 5-LO activity [22].
Our results also show that IL-I increases monocyte 5-LU and
FLAP mRNA expression. The increase in steady state 5-LU
mRNA levels with IL-I was statistically significant following 36
hours of incubation. The increase in monocyte FLAP mRNA
steady state levels was modest and observed at 24 and 36 hours of
incubation, but did not reach statistical significance. The biologi-
cal significance of these increases in steady state mRNA levels of
5-LU and FLAP remains uncertain for two reasons: first, differ-
ences in activated LTB4 release between IL-I-treated and control
monocytes were notable at 16 hours of incubation (Fig. 1C), prior
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Fig. 7. Proposed scheme for the effects of
proinfiammatoiy (IL-i and IFN-y) and anti-
inflammato,y TH-2 cytokines (IL-4 and IL-13)
on the 5- and 15-LO pathways.
to significant increases in 5-LU mRNA expression; second, the
increases in mRNA levels did not lead to increases in monocyte
5-LU or FLAP protein expression. This dissociation between
changes in 5-LU and FLAP mRNA levels on one hand, and
protein expression on the other, may not be totally surprising
since the mechanisms required to increase protein expression are
different from those necessary for increasing steady state mRNA
levels. In this regard, Pouliot et al demonstrated an increase in
polymorphonuclear cell 5-LU protein expression due to treatment
with GM-CSF, which was not accompanied by changes in 5-LU
mRNA levels [251. Alternatively, there may have been an increase
in 5-LU or FLAP protein expression that could not be detected by
our standard Western blotting techniques.
IFN-y exerted insignificant changes in 5-LU and FLAP mRNA
and protein steady state levels, yet it caused significant increases
in activated LTB4 release. LTB4 production is a composite of
multifactorial events and is influenced by cellular PLA2 activity,
5-LO, FLAP, and LTA4 hydrolase activities, the state of activa-
tion of the cell, as well as the activity of other enzyme systems that
utilize arachidonic acid such as cyclooxygenase. IFN-y may there-
fore influence LTB4 production by several means other than
changes in 5-LU or FLAP expression. Effects on arachidonic acid
availability are unlikely because other investigators found no
change in arachidonic acid release following monocyte stimula-
tion with IFN-y [201. Increased expression or activity of enzymes
acting downstream to 5-LU such as LTA4 hydrolase may contrib-
ute to the increase in stimulated LTB4 production. In this regard,
we have recently reported [26] that IFN-y (100 pM) increases
monocyte LTA4 hydrolase mRNA expression (Fig. 6).
IL-i and IFN-y are proinflammatory cytokines produced locally
at inflammatory sites. IL-i is largely produced by monocytes and
tissue macrophages and acts in several ways to amplify the
inflammatory response [81. In this regard, it enhances the prolif-
eration of CD4 positive T cells and the growth and differentiation
of B cells. It also acts on macrophages to induce the synthesis of
IL-6 and IL-8, which in turn promote leukocyte activation. IFN-y
is largely produced by TH-1 cells. It up-regulates MHC class-I and
class II antigen expression and is a potent activator of macro-
phages [9, 10, 27]. In addition to these effects on the immune
system, the current results show that IL-I and IFN-y also exert
proinflammatory effects by enhancing the release of LTB4 from
activated monocytes. In turn, increased LTB4 production is likely
to enhance proinflammatory cytokine release by monocytes and T
cells, thus further amplifying inflammation [28—301.
IL-4 and IL-13 are immunoregulatory lymphokines secreted by
TH 2 lymphocytes [31, 32]. These cytokines have already been
demonstrated to share several properties most notably their
ability to down-regulate monocyte inflammatory responses (11,
33, 34]. They decrease monocyte release of proinflammatoty
cytokines such as IL-i and TNF-a, and increase the release of
IL-I receptor antagonist [11]. Inhibition of monocyte activated
LTB4 release by these lymphokines is in keeping with their other
anti-inflammatory effects, and may interrupt the positive feedback
loop by which LTB4 enhances proinflammatory cytokine release
[28 —30].
Regulation of the monocyte arachidonate 15-LU by specific
cytokines has recently been demonstrated [14, 15]. In this regard
IL-4 and IL-13 induce 15-LU expression and activity, whereas
IFN-y blocks this induction. The current findings extend the
previous observations by demonstrating contrasting effects on
monocyte arachidonate 5-LU pathway by proinflammatory and
TH-2-derived cytokines. The elucidation of IL-4 and IL-13 as key
regulators in the 5-LU pathway is an important step in under-
standing the regulation between the 5- and 15-LU pathways. In
Figure 7 we propose a schematic representation to highlight the
effects of selected cytokines on the key biosynthetic enzymes,
accessory proteins, and bioactive products of the 5- and 15-LU
pathways.
Arachidonic acid/
5-LO
(FLAP)
LTA4
IL-13
IFN-Y
IFN-Y
Overall effects:
15-S-H ETE/Lipoxins
Inhibition of
leukocyte
activation
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